We read with interest the Article by Qifang Bi and colleagues,[@bib1] in which they reported a household secondary attack rate, as detected by repeated RT-PCR tests, of approximately 11%. We have found substantially higher attacks rates in western Norway through detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The first case of COVID-19 in Norway was identified in Bergen on Feb 28, 2020, before the outbreak was declared a pandemic, allowing rigorous testing of suspected cases before and during the rise in confirmed cases. All suspected COVID-19 cases in the peak period between Feb 28 and April 4 were referred to the Bergen municipality emergency room for centralised evaluation and testing according to a strict exposure likelihood algorithm, allowing an overview of the early virus spread in the population. If a family was exposed, only the index case was tested for SARS-CoV-2 infection. Both cases and household members were tested for specific antibodies to the receptor binding domain of SARS-CoV-2, as described by Stadlbauer and colleagues,[@bib2] at 6 weeks after the index patient tested positive by RT-PCR.

Of 158 cases, 125 (79%) tested positive for antibodies and 12 (8%) were defined as borderline. In 77 household members, 24 (31%) tested positive and two (3%) were borderline. Our results show that detection of seroconversion might provide a more accurate picture of attack rates in households than intermittent RT-PCR testing.
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FK reports that an assay used to screen for seroconversion was developed in his laboratory and that Mount Sinai has filed patent applications to protect that assay, has licensed its use for several companies, and is commercialising the assay. All other authors declare no competing interests.
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